Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) EBIT (2022 - 2025)

Historic EBIT for Scilex Holding (SCLX) over the last 4 years, with Q3 2025 value amounting to -$186.5 million.

  • Scilex Holding's EBIT fell 83644.63% to -$186.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$263.3 million, marking a year-over-year decrease of 25893.1%. This contributed to the annual value of -$83.4 million for FY2024, which is 2089.61% up from last year.
  • According to the latest figures from Q3 2025, Scilex Holding's EBIT is -$186.5 million, which was down 83644.63% from -$20.5 million recorded in Q2 2025.
  • In the past 5 years, Scilex Holding's EBIT registered a high of -$8.8 million during Q1 2022, and its lowest value of -$186.5 million during Q3 2025.
  • Moreover, its 4-year median value for EBIT was -$19.9 million (2024), whereas its average is -$31.6 million.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 4867.41% in 2024, then tumbled by 83644.63% in 2025.
  • Quarter analysis of 4 years shows Scilex Holding's EBIT stood at -$19.7 million in 2022, then rose by 7.1% to -$18.3 million in 2023, then plummeted by 54.76% to -$28.4 million in 2024, then plummeted by 557.15% to -$186.5 million in 2025.
  • Its EBIT was -$186.5 million in Q3 2025, compared to -$20.5 million in Q2 2025 and -$27.9 million in Q1 2025.